Document is current
Any future updates will be listed below
-
Authors
de Oliveira, Thiago Bueno https://orcid.org/0000-0002-6472-3596
Marta, Gustavo Nader https://orcid.org/0000-0002-3298-3684
de Castro Junior, Gilberto https://orcid.org/0000-0001-8765-3044
Kowalski, Luiz Paulo https://orcid.org/0000-0002-0481-156X
- License Information
-
More Information
Article History
Accepted: 1 March 2021
First Online: 27 August 2021
Declarations
:
: TBO: received support for his advisory work from pharmaceutical companies including Merck Serono, Merck Sharp and Dohme, Bristol Myers Squibb, Janssen and Bayer. He has also received fees for Speakers’ bureau from Merck Serono, Merck Sharp and Dohme, Bristol Myers Squibb. GNM has no conflicts of interests to declare related to this article. LPK has no conflicts of interests to declare related to this article. GCJ: honoraria from Merck Sharp and Dohme, and Bristol Myers Squibb; advisory/consultancy for Merck Sharp and Dohme, Bristol Myers Squibb, and Merck Serono; speakers bureau/expert testimony for Merck Sharp and Dohme, and Bristol Myers Squibb; research grant/funding to institution from Merck Sharp and Dohme, Bristol Myers Squibb, and Merck Serono; and personal fees for travel/accommodation/expenses from Merck Sharp and Dohme, and Bristol Myers Squibb.
